Contact Information
Email
m****@adctherapeutics.com
Unlock
Company Information
Technologies
Salesforce
Route 53
Mimecast
Outlook
Formstack
Vimeo
Google Font API
Google Analytics
Cedexis Radar
LiveRamp
Adobe Media Optimizer
Mobile Friendly
Typekit
reCAPTCHA
WordPress.org
Google Tag Manager
Remote
Keywords
biotechnology: pharmaceutical preparations
health care
biotechnology research
antibody drug conjugates
cancer treatment
hematology
solid tumors
loncastuximab tesirine-lpyl
adct-602
targeted therapy
cytotoxic molecule
therapeutic window
innovative collaborations
pbd technology
fda approval
biologics license application
targeted investments
adc portfolio
cytotoxic activity
dna topoisomerase i
clinical trials
phase 3 trials
tumor cells
dosing regimens
patient outcomes
r&d capabilities
biotechnology startup
oncology research
cancer patients
ethical practices
innovative science
research grants
early access programs
employee wellness program
medical affairs
camaraderie
entrepreneurial spirit
regulatory compliance
global presence
equity grants
comprehensive benefits package
health insurance
collaborative environment
clinical data
strategic partnerships
industry veterans
cancer treatment innovations
compensation package
work-life balance
ongoing learning
employee development
stock purchase plan
quality assurance
biotechnology
adcs
hematological malignancies
oncology
targeted therapies
precision medicine
innovative payloads
pyrrolobenzodiazepine technology
investigational drugs
zynlonta
oncologists
healthcare professionals
research & development
market presence
u.s. market
european market
cancer therapies
patient-centric approach
unmet medical needs
competitive landscape
biopharmaceuticals
drug development
therapeutic innovation
advanced cancer treatments
oncology market
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans